TREA

James F. Callahan

Follow

Person

  • Collegeville, PA, US
People

Patents Grantslast 30 patents

  • Information Patent Grant

    Bisaryl heterocycles as NRF2 activators
    • Patent number 11,117,905
    • Issue date Sep 14, 2021
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    • James Francis Callahan
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Bisaryl amides as NRF2 activators
    • Patent number 11,078,216
    • Issue date Aug 3, 2021
    • GlaxoSmithKline Intellectual Property Development Limited
    • James Francis Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Nrf2 regulators
    • Patent number 10,604,509
    • Issue date Mar 31, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey K. Kerns
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Nrf2 regulators
    • Patent number 10,485,806
    • Issue date Nov 26, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey K. Kerns
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Biaryl pyrazoles as NRF2 regulators
    • Patent number 10,364,256
    • Issue date Jul 30, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • James Callahan
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Arylcyclohexyl pyrazoles as NRF2 regulators
    • Patent number 10,351,530
    • Issue date Jul 16, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • James Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    NRF2 regulators
    • Patent number 10,272,095
    • Issue date Apr 30, 2019
    • GlaxoSmithKline Intellectual Propert Development Limited
    • Jeffrey K. Kerns
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Calcilytic compounds
    • Patent number 9,227,914
    • Issue date Jan 5, 2016
    • GlaxoSmithKline, LLC
    • Robert W. Marquis
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Calcilytic compounds
    • Patent number 8,980,950
    • Issue date Mar 17, 2015
    • GlaxoSmithKline, LLC
    • Robert W. Marquis
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Calcilytic compounds
    • Patent number 8,586,631
    • Issue date Nov 19, 2013
    • GlaxoSmithKline, LLC
    • Robert W. Marquis
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Calcilytic compounds
    • Patent number 8,399,517
    • Issue date Mar 19, 2013
    • GlaxoSmithKline, LLC
    • Robert W. Marquis
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inh...
    • Patent number 8,354,416
    • Issue date Jan 15, 2013
    • Glaxo Group Limited
    • James F. Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds
    • Patent number 8,207,176
    • Issue date Jun 26, 2012
    • Glaxo Group Limited
    • James F. Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Dual pharmacophores—PDE4-muscarinic antagonistics
    • Patent number 8,084,449
    • Issue date Dec 27, 2011
    • Glaxo Group Limited
    • James Francis Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Dual pharmacophores—PDE4-muscarinic antagonistics
    • Patent number 8,071,588
    • Issue date Dec 6, 2011
    • Glaxo Group Limited
    • James Francis Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Dual pharmacophores—PDE4-muscarinic antagonistics
    • Patent number 8,067,408
    • Issue date Nov 29, 2011
    • Glaxo Group Limited
    • James Francis Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Calcilytic compounds
    • Patent number 7,829,594
    • Issue date Nov 9, 2010
    • GlaxoSmithKline, LLC
    • Robert W. Marquis
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds
    • Patent number 7,678,801
    • Issue date Mar 16, 2010
    • Glaxo Group Limited
    • James F. Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds
    • Patent number 7,674,789
    • Issue date Mar 9, 2010
    • Glaxo Group Limited
    • James F. Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds
    • Patent number 7,629,350
    • Issue date Dec 8, 2009
    • SmithKline Beecham Corporation
    • Jeffrey C. Boehm
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds
    • Patent number 7,550,480
    • Issue date Jun 23, 2009
    • SmithKline Beecham Corporation
    • Jeffrey Charles Boehm
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Calcilytic compounds
    • Patent number 7,514,473
    • Issue date Apr 7, 2009
    • SmithKline Beecham, Corp.
    • Robert W. Marquis
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Chemical compounds
    • Patent number 7,482,455
    • Issue date Jan 27, 2009
    • SmithKline Beecham Corporation
    • Joelle L. Burgess
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydrop...
    • Patent number 7,479,558
    • Issue date Jan 20, 2009
    • Glaxo Group Limited
    • James F. Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    NF-κB inhibitors
    • Patent number 7,375,131
    • Issue date May 20, 2008
    • SmithKlineBeecham Corp.
    • James F. Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    NF-κb inhibitors
    • Patent number 7,300,952
    • Issue date Nov 27, 2007
    • SmithKline Beecham Corporation
    • James F. Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Calcilytic compounds
    • Patent number 7,202,261
    • Issue date Apr 10, 2007
    • NPS Pharmaceuticals, Inc.
    • Eric G. Del Mar
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    NF-κB inhibitors
    • Patent number 7,183,311
    • Issue date Feb 27, 2007
    • SmithKline Beecham Corporation
    • James F. Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    NF-κB inhibitors
    • Patent number 7,166,639
    • Issue date Jan 23, 2007
    • SmithKline Beecham Corporation
    • Zehong Wan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Calcilytic compounds
    • Patent number 7,109,238
    • Issue date Sep 19, 2006
    • Smith Kline Beecham Corporation
    • Maria Amparo Lago
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    Nrf2 REGULATORS
    • Publication number 20230047296
    • Publication date Feb 16, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey K. KERNS
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    Nrf2 REGULATORS
    • Publication number 20200079759
    • Publication date Mar 12, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey K. KERNS
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    BISARYL HETEROCYCLES AS NRF2 ACTIVATORS
    • Publication number 20200062781
    • Publication date Feb 27, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • James Francis CALLAHAN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    BISARYL AMIDES AS NRF2 ACTIVATORS
    • Publication number 20190330238
    • Publication date Oct 31, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • James Francis CALLAHAN
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Nrf2 REGULATORS
    • Publication number 20190224212
    • Publication date Jul 25, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey K. Kerns
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    BIARYL PYRAZOLES AS NRF2 REGULATORS
    • Publication number 20180282349
    • Publication date Oct 4, 2018
    • GlaxoSmithKline Intellectual Property Development Limited
    • James CALLAHAN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ARYLCYCLOHEXYL PYRAZOLES AS NRF2 REGULATORS
    • Publication number 20180282283
    • Publication date Oct 4, 2018
    • GlaxoSmithKline Intellectual Property Development Limited
    • James CALLAHAN
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Nrf2 REGULATORS
    • Publication number 20180179187
    • Publication date Jun 28, 2018
    • Jeffrey K. KERNS
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Calcilytic Compounds
    • Publication number 20150183723
    • Publication date Jul 2, 2015
    • GlaxoSmithKline, LLC
    • Robert W. Marquis
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CALCILYTIC COMPOUNDS
    • Publication number 20140057980
    • Publication date Feb 27, 2014
    • GlaxoSmithKline, LLC
    • Robert W. Marquis
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Calcilytic Compounds
    • Publication number 20130158114
    • Publication date Jun 20, 2013
    • GlaxoSmithKline, LLC
    • Robert W. Marquis
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Calcilytic Compounds
    • Publication number 20110054021
    • Publication date Mar 3, 2011
    • GLAXOSMITHKLINE LLC
    • ROBERT W. MARQUIS
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL COMPOUNDS
    • Publication number 20100093765
    • Publication date Apr 15, 2010
    • James F. CALLAHAN
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL COMPOUNDS
    • Publication number 20100093766
    • Publication date Apr 15, 2010
    • James F. CALLAHAN
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Novel Compounds
    • Publication number 20090239846
    • Publication date Sep 24, 2009
    • Glaxo Group Limited
    • James F. Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL COMPOUNDS
    • Publication number 20090239897
    • Publication date Sep 24, 2009
    • SmithKline Beecham Corporation
    • JEFFREY CHARLES BOEHM
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Dual Pharmacophores - PDE4-Muscarinic Antagonistics
    • Publication number 20090203677
    • Publication date Aug 13, 2009
    • Glaxo Group Limited
    • James Francis Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Dual Pharmacophores - PDE4-Muscarinic Antagonistics
    • Publication number 20090203657
    • Publication date Aug 13, 2009
    • Glaxo Group Limited
    • James Francis Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Dual Pharmacophores - PDE4-Muscarinic Antagonistics
    • Publication number 20090197871
    • Publication date Aug 6, 2009
    • Glaxo Group Limited
    • James Francis Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Calcilytic Compounds
    • Publication number 20090163589
    • Publication date Jun 25, 2009
    • SmithKline Beecham Corp.
    • Robert W. Marquis
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Novel Compounds
    • Publication number 20090156597
    • Publication date Jun 18, 2009
    • Glaxo Group Limited
    • James F. Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Novel Compounds
    • Publication number 20090069318
    • Publication date Mar 12, 2009
    • James Francis Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydrop...
    • Publication number 20090048444
    • Publication date Feb 19, 2009
    • Glaxo Group Limited
    • James F. Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Chemical Compounds
    • Publication number 20080262040
    • Publication date Oct 23, 2008
    • SmithKline Beecham Corporation
    • James Francis Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Process For Preparing Pyrido[2,3-D]Pyrimidin-7-One And 3,4-Dihydrop...
    • Publication number 20080096905
    • Publication date Apr 24, 2008
    • Glaxo Group Limited
    • James Francis Callahan
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Novel Compounds
    • Publication number 20080051416
    • Publication date Feb 28, 2008
    • SmithKline Beecham Corporation
    • Jeffrey Charles Boehm
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CALCILYTIC COMPOUNDS
    • Publication number 20070249702
    • Publication date Oct 25, 2007
    • Eric G. Del Mar
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Novel compounds
    • Publication number 20060293348
    • Publication date Dec 28, 2006
    • SmithKline Beecham Corporation
    • Jeffrey C Boehm
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydrop...
    • Publication number 20060258687
    • Publication date Nov 16, 2006
    • Jeffrey C. Boehm
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Novel compounds
    • Publication number 20060235030
    • Publication date Oct 19, 2006
    • James F. Callahan
    • C07 - ORGANIC CHEMISTRY